JF
Jessica Fye JP Morgan Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
61
Avg Return
Past Year
Past Year
7%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
28.6%
Neutral
57.1%
Negative
14.3%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Devices
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $26 |
45%
upside
| 1 | +17% |
0
%
| 4 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $25 |
13%
downside
| 1 | – |
–
| 3 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $23 |
69%
upside
| 1 | – |
–
| 27 Oct ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $199 |
17%
upside
| 1 | +11% |
0
%
| 27 Oct ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $65 |
9%
downside
| 1 | – |
–
| 27 Oct ‘25 2 months ago |
|
|
|
Underweight
Maintained
| $25 |
40%
downside
| 1 | -13% |
0
%
| 23 Oct ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $120 |
10%
upside
| 1 | – |
–
| 23 Oct ‘25 2 months ago |
|